Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Experimental Neoplasms
go back to main search page
Accession:DOID:9002170 term browser browse the term
Definition:Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Synonyms:exact_synonym: Experimental Neoplasm
 primary_id: MESH:D009374
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
Experimental Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
JBrowse link
G ARL6IP5 ADP ribosylation factor like GTPase 6 interacting protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29545876 NCBI chr13:50,509,777...50,538,004
Ensembl chr13:50,509,519...50,538,966
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator ISO CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr 4:98,333,431...98,390,012
Ensembl chr 4:98,333,459...98,389,457
JBrowse link
G AXL AXL receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914
JBrowse link
G BCR BCR activator of RhoGEF and GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
JBrowse link
G BSG basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21165561 NCBI chr 2:77,735,586...77,743,451 JBrowse link
G CCND1 cyclin D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27224422 NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
JBrowse link
G CDK4 cyclin dependent kinase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
JBrowse link
G CTCF CCCTC-binding factor ISO human breast cancer cells in mouse model RGD PMID:21896759 RGD:151356745 NCBI chr 6:28,188,002...28,261,009
Ensembl chr 6:28,195,647...28,261,009
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 treatment ISO human cancer cells in mouse model RGD PMID:26719540 RGD:11520844 NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584
JBrowse link
G ENO2 enolase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22613180 NCBI chr 5:63,799,927...63,809,067
Ensembl chr 5:63,799,930...63,809,410
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14612517 NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
JBrowse link
G ERGIC3 ERGIC and golgi 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27588471 NCBI chr17:38,884,830...38,899,140
Ensembl chr17:38,885,117...38,899,138
JBrowse link
G ESRRA estrogen related receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr 2:7,803,504...7,812,868
Ensembl chr 2:7,803,510...7,813,098
JBrowse link
G F2R coagulation factor II thrombin receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17374729 NCBI chr 2:85,642,794...85,659,133
Ensembl chr 2:85,641,474...85,656,636
JBrowse link
G HDAC6 histone deacetylase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr  X:42,917,911...42,941,894
Ensembl chr  X:42,917,964...42,941,887
JBrowse link
G HGF hepatocyte growth factor ISO CTD Direct Evidence: therapeutic CTD PMID:21273587 NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:3433577 PMID:11552296 PMID:26558449 NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
JBrowse link
G HRH2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:6224980 NCBI chr 2:81,883,670...81,932,464
Ensembl chr 2:81,883,673...81,932,275
JBrowse link
G IFNB1 interferon beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:2297754 NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: therapeutic CTD PMID:15711825 NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
JBrowse link
G IL12A interleukin 12A ISO CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr13:99,733,394...99,741,078
Ensembl chr13:99,733,394...99,741,078
JBrowse link
G IL12B interleukin 12B ISO CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
JBrowse link
G IL2 interleukin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:1949363 PMID:3495671 PMID:22306178 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
JBrowse link
G ITGAV integrin subunit alpha V treatment ISO human cells in rat model RGD PMID:20841470 RGD:152998949 NCBI chr15:91,604,666...91,711,843
Ensembl chr15:91,604,676...91,711,851
JBrowse link
G KIF11 kinesin family member 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17974955 NCBI chr14:104,125,839...104,177,381
Ensembl chr14:104,125,898...104,177,379
JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243 NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
JBrowse link
G LDHA lactate dehydrogenase A ISO RGD PMID:11085542 RGD:1600281 NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,812,453...40,826,715
JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464
JBrowse link
G MAPK7 mitogen-activated protein kinase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr12:60,144,138...60,148,743
Ensembl chr12:60,144,136...60,158,739
JBrowse link
G MIR143 microRNA mir-143 ISO CTD Direct Evidence: therapeutic CTD PMID:28736328 PMID:31152816 NCBI chr 2:150,578,738...150,578,817
Ensembl chr 2:150,578,738...150,578,817
JBrowse link
G MIR381 microRNA mir-381 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816
G NQO1 NAD(P)H quinone dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:9496914 PMID:21034357 NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9205081 NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
JBrowse link
G PARG poly(ADP-ribose) glycohydrolase ISO CTD Direct Evidence: therapeutic CTD PMID:33044785 NCBI chr14:90,338,599...90,481,015
Ensembl chr14:90,338,510...90,480,989
JBrowse link
G PCNA proliferating cell nuclear antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
JBrowse link
G POLR1H RNA polymerase I subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:16609701 NCBI chr 7:22,626,871...22,631,557
Ensembl chr 7:22,626,846...22,631,545
JBrowse link
G PRL prolactin treatment ISO RGD PMID:26983879 RGD:152177690 NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
JBrowse link
G PRNP prion protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21265952 NCBI chr17:13,694,195...13,705,126
Ensembl chr17:13,694,190...13,705,124
JBrowse link
G PUF60 poly(U) binding splicing factor 60 ISO CTD Direct Evidence: therapeutic CTD PMID:21435101 NCBI chr 4:812,137...824,321
Ensembl chr 4:812,131...824,318
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 disease_progression ISO RGD PMID:24244675 RGD:152995458 NCBI chr16:24,109,934...24,250,019
Ensembl chr16:24,109,939...24,311,132
JBrowse link
G SPARC secreted protein acidic and cysteine rich ISO CTD Direct Evidence: therapeutic CTD PMID:20164124 NCBI chr16:71,368,164...71,380,972
Ensembl chr16:71,357,586...71,381,161
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21852811 NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
JBrowse link
G STIM1 stromal interaction molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27863410 NCBI chr 9:6,066,612...6,270,090
Ensembl chr 9:6,066,617...6,270,575
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: therapeutic CTD PMID:1674182 PMID:3361654 PMID:12627504 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TNFSF10 TNF superfamily member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:17767197 PMID:24345465 NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
JBrowse link
G TOB1 transducer of ERBB2, 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12756225 NCBI chr12:27,116,579...27,119,906
Ensembl chr12:27,116,584...27,117,614
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12756225 PMID:27137931 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
JBrowse link
G TP63 tumor protein p63 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25739959 NCBI chr13:127,115,990...127,347,082
Ensembl chr13:127,116,105...127,347,068
JBrowse link
G TRIM47 tripartite motif containing 47 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31981573 NCBI chr12:5,535,259...5,539,721
Ensembl chr12:5,535,236...5,539,715
JBrowse link
G TXN thioredoxin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr 1:251,264,180...251,278,000
Ensembl chr 1:251,263,175...251,277,988
JBrowse link
G URI1 URI1 prefoldin like chaperone ISO CTD Direct Evidence: marker/mechanism CTD PMID:21397856 NCBI chr 6:40,043,320...40,110,540
Ensembl chr 6:40,023,595...40,110,536
JBrowse link
G VEGFA vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:20376344 PMID:20932960 PMID:28574600 NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
JBrowse link
Avian Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G RHOB ras homolog family member B ISO RGD PMID:1710770 RGD:704375 NCBI chr 3:117,773,400...117,777,569
Ensembl chr 3:117,773,405...117,777,574
JBrowse link
Carcinoma, Lewis Lung term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C3 complement C3 treatment ISO RGD PMID:16947020 RGD:7401280 NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
JBrowse link
G COQ7 coenzyme Q7, hydroxylase susceptibility ISO RGD PMID:23166727 RGD:10402105 NCBI chr 3:26,366,006...26,373,604
Ensembl chr 3:26,366,000...26,373,584
JBrowse link
G CSF1R colony stimulating factor 1 receptor ameliorates ISO mouse cell line in a mouse model RGD PMID:20008303 RGD:150524291 NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
JBrowse link
G IL18 interleukin 18 treatment ISO RGD PMID:16767432 RGD:8655941 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
JBrowse link
G IL2 interleukin 2 treatment ISO RGD PMID:9399664 RGD:8663451 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
JBrowse link
G IRAK3 interleukin 1 receptor associated kinase 3 ISO RGD PMID:21278795 RGD:36049796 NCBI chr 5:30,524,704...30,601,067
Ensembl chr 5:30,526,793...30,609,921
JBrowse link
G JAM3 junctional adhesion molecule 3 ISO RGD PMID:15994945 RGD:7488936 NCBI chr 9:60,629,245...60,738,979
Ensembl chr 9:60,613,400...60,738,924
JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 ameliorates ISO mouse cell line in a mouse model RGD PMID:29907597 RGD:151665504 NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor treatment ISO mouse cell line in a mouse model RGD PMID:26111447 RGD:150521531 NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
JBrowse link
G TXNRD1 thioredoxin reductase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16565519 NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
JBrowse link
Ehrlich tumor carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CD40 CD40 molecule treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
JBrowse link
G CD40LG CD40 ligand treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr  X:111,778,666...111,788,901
Ensembl chr  X:111,778,493...111,789,709
JBrowse link
G CEACAM20 CEA cell adhesion molecule 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34605108 NCBI chr 6:51,010,317...51,031,579
Ensembl chr 6:51,009,689...51,031,550
JBrowse link
Experimental Leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CBL Cbl proto-oncogene treatment ISO RGD PMID:20890046 RGD:11038805 NCBI chr 9:46,416,937...46,512,855
Ensembl chr 9:46,416,938...46,512,834
JBrowse link
G CBX7 chromobox 7 ISO RGD PMID:25434821 RGD:11352713 NCBI chr 5:9,070,312...9,090,467
Ensembl chr 5:9,070,353...9,087,634
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO RGD PMID:10090949 RGD:11251764 NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
JBrowse link
G FGFR1 fibroblast growth factor receptor 1 treatment ISO RGD PMID:22781593 RGD:11352669 NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
JBrowse link
G IL1A interleukin 1 alpha treatment ISO RGD PMID:2117483 RGD:11051972 NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
JBrowse link
G LAT2 linker for activation of T cells family member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32587277 NCBI chr 3:11,353,213...11,372,100
Ensembl chr 3:11,352,579...11,372,092
JBrowse link
G NRAS NRAS proto-oncogene, GTPase induced ISO DNA:transversion mutation, loss of heterozygosity:cds: RGD PMID:9142215 RGD:11535063 NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
JBrowse link
G PTPN11 protein tyrosine phosphatase non-receptor type 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32417439 NCBI chr14:39,202,165...39,292,041
Ensembl chr14:39,202,169...39,292,003
JBrowse link
G RUNX1 RUNX family transcription factor 1 treatment ISO RGD PMID:19236814 RGD:11251683 NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
JBrowse link
Experimental Liver Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 ISO RGD PMID:15853769 RGD:1598580 NCBI chr15:75,402,296...75,487,092
Ensembl chr15:75,402,396...75,486,403
JBrowse link
G ADSL adenylosuccinate lyase ISO protein:increased activity:liver (rat) RGD PMID:2937404 RGD:1598766 NCBI chr 5:8,027,799...8,045,480
Ensembl chr 5:8,025,508...8,047,603
JBrowse link
G AFP alpha fetoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:24012840 PMID:32961231 NCBI chr 8:69,677,690...69,698,864
Ensembl chr 8:69,677,690...69,698,864
JBrowse link
G AGPS alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr15:83,146,063...83,285,905
Ensembl chr15:83,146,002...83,391,984
JBrowse link
G ALAS2 5'-aminolevulinate synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:47,871,519...47,896,041
Ensembl chr  X:47,871,523...47,896,000
JBrowse link
G APOA4 apolipoprotein A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
JBrowse link
G APOC2 apolipoprotein C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 6:51,404,219...51,406,302 JBrowse link
G ARID1A AT-rich interaction domain 1A disease_progression ISO RGD PMID:26569409 RGD:11344640 NCBI chr 6:84,049,729...84,124,302
Ensembl chr 6:84,049,087...84,123,349
JBrowse link
G ARRB2 arrestin beta 2 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:21167192 RGD:5509890 NCBI chr12:52,161,776...52,170,362
Ensembl chr12:52,161,778...52,170,342
JBrowse link
G ATP7A ATPase copper transporting alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr  X:61,972,544...62,110,058
Ensembl chr  X:61,972,991...62,110,048
JBrowse link
G ATP7B ATPase copper transporting beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr11:15,892,549...15,942,070
Ensembl chr11:15,876,612...15,942,064
JBrowse link
G BAK1 BCL2 antagonist/killer 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 7:29,808,849...29,815,345 JBrowse link
G BBC3 BCL2 binding component 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 6:53,037,103...53,046,902
Ensembl chr 6:53,037,104...53,046,887
JBrowse link
G BCL2L1 BCL2 like 1 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:10426811 PMID:22414765 PMID:28100771 RGD:11353865 NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 ISO mRNA, protein:increased expression:liver RGD PMID:18246794 RGD:2293125 NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
JBrowse link
G CA3 carbonic anhydrase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 4:51,227,485...51,237,861
Ensembl chr 4:51,227,485...51,237,844
JBrowse link
G CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ISO protein:increased activity:liver (rat) RGD PMID:13618893 RGD:5132586 NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
JBrowse link
G CCL20 C-C motif chemokine ligand 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30603057 NCBI chr15:129,172,743...129,176,069 JBrowse link
G CCNB1 cyclin B1 ISO mRNA:increased expression:liver RGD PMID:17342310 RGD:2315991 NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
JBrowse link
G CCND1 cyclin D1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:17055752 PMID:28100771 RGD:2289139 NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
JBrowse link
G CCNDBP1 cyclin D1 binding protein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:16501603 NCBI chr 1:128,253,111...128,269,534
Ensembl chr 1:128,253,035...128,269,452
JBrowse link
G CCNG1 cyclin G1 ISO RGD PMID:27982046 RGD:151361200 NCBI chr16:60,349,255...60,356,737
Ensembl chr16:60,349,258...60,356,738
JBrowse link
G CCNG2 cyclin G2 ISO RGD PMID:27982046 RGD:151361200 NCBI chr 8:72,790,394...72,800,553
Ensembl chr 8:72,791,703...72,800,551
JBrowse link
G CD40LG CD40 ligand ISO RGD PMID:19035311 RGD:5491179 NCBI chr  X:111,778,666...111,788,901
Ensembl chr  X:111,778,493...111,789,709
JBrowse link
G CD63 CD63 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 5:21,172,275...21,176,225
Ensembl chr 5:21,172,283...21,176,232
JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:25319454 NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO protein:decreased expression:liver: RGD PMID:8640740 RGD:8662309 NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
JBrowse link
G CDKN1C cyclin dependent kinase inhibitor 1C disease_progression ISO mRNA:increased expression:liver (rat)
protein:increased expression:liver (rat)
protein:decreased expression:liver (rat)
RGD PMID:3965145 PMID:19533683 PMID:26606000 RGD:11354707 RGD:152998958 RGD:2315050 NCBI chr 2:2,019,391...2,022,092
Ensembl chr 2:2,019,830...2,021,853
JBrowse link
G COPS5 COP9 signalosome subunit 5 ISO protein:increased expression:liver (rat) RGD PMID:26606000 RGD:11354707 NCBI chr 4:67,740,528...67,758,153
Ensembl chr 4:67,739,251...67,758,150
JBrowse link
G CP ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 severity ISO mRNA:decreased expression:liver RGD PMID:3387993 RGD:2303406 NCBI chr15:113,210,038...113,339,086
Ensembl chr15:113,150,157...113,339,078
JBrowse link
G CTNNB1 catenin beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11280770 PMID:20118494 PMID:21147764 NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
JBrowse link
G CXCL9 C-X-C motif chemokine ligand 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO mRNA:increased expression:liver RGD PMID:22687991 RGD:7296954 NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11376689 PMID:21147764 NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18056438 NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
JBrowse link
G CYP2F1 cytochrome P450 family 2 subfamily F member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 6:49,014,912...49,032,207
Ensembl chr 6:49,017,008...49,029,388
JBrowse link
G DHODH dihydroorotate dehydrogenase (quinone) ISO protein:increased activity:liver (rat) RGD PMID:6331524 RGD:5132618 NCBI chr 6:14,942,898...14,956,000
Ensembl chr 6:14,942,933...14,955,997
JBrowse link
G DTYMK deoxythymidylate kinase ISO protein:increased activity:tumor (rat) RGD PMID:6244089 RGD:5133686 NCBI chr15:140,248,071...140,255,803
Ensembl chr15:140,248,079...140,255,805
JBrowse link
G ENO2 enolase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr 5:63,799,927...63,809,067
Ensembl chr 5:63,799,930...63,809,410
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO RGD PMID:7260898 RGD:11252158 NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
JBrowse link
G F12 coagulation factor XII ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 2:80,527,451...80,544,835
Ensembl chr 2:80,527,446...80,544,828
JBrowse link
G FAS Fas cell surface death receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
JBrowse link
G FOXM1 forkhead box M1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15082532 NCBI chr 5:67,246,219...67,263,215
Ensembl chr 5:67,245,694...67,263,211
Ensembl chr 5:67,245,694...67,263,211
JBrowse link
G GJB1 gap junction protein beta 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:1336494 PMID:18308698 RGD:7349398 NCBI chr  X:57,241,990...57,249,496
Ensembl chr  X:57,242,045...57,249,885
JBrowse link
G GJB2 gap junction protein beta 2 ISO RGD PMID:1336494 RGD:7349398 NCBI chr11:774,090...781,252
Ensembl chr11:775,166...775,846
JBrowse link
G GLUL glutamate-ammonia ligase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:21147764 NCBI chr 9:123,751,551...123,762,575
Ensembl chr 9:123,751,548...123,762,547
JBrowse link
G GRP gastrin releasing peptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr 1:161,708,815...161,721,986
Ensembl chr 1:161,708,812...161,721,782
JBrowse link
G HAT1 histone acetyltransferase 1 ISO protein:increased expression:liver RGD PMID:17182829 RGD:2316578 NCBI chr15:78,022,147...78,079,669
Ensembl chr15:78,022,207...78,079,608
JBrowse link
G HGF hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11896611 NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism CTD PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622 NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
JBrowse link
G HTR2C 5-hydroxytryptamine receptor 2C ISO protein:increased expression:brainstem, cerebral cortex RGD PMID:17258772 RGD:1624998 NCBI chr  X:94,053,415...94,313,352
Ensembl chr  X:94,053,456...94,313,355
JBrowse link
G IGF2 insulin like growth factor 2 treatment ISO RGD PMID:22425635 RGD:10402567 NCBI chr 2:1,469,183...1,496,417 JBrowse link
G IGF2R insulin like growth factor 2 receptor ISO RGD PMID:9652747 PMID:15057872 RGD:2311623 RGD:2311630 NCBI chr 1:7,369,485...7,472,480
Ensembl chr 1:7,368,103...7,472,548
JBrowse link
G IKBKG inhibitor of nuclear factor kappa B kinase regulatory subunit gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr  X:125,035,575...125,056,445
Ensembl chr  X:125,036,508...125,056,453
JBrowse link
G IL6 interleukin 6 disease_progression ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:blood serum (mouse)
CTD
RGD
PMID:26297436 PMID:26569409 RGD:11344640 NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
JBrowse link
G INSR insulin receptor disease_progression ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat) RGD PMID:15520221 RGD:2306052 NCBI chr 2:71,797,209...71,939,923
Ensembl chr 2:71,797,204...71,936,104
JBrowse link
G JAK2 Janus kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
JBrowse link
G KAT6A lysine acetyltransferase 6A ISO protein:increased expression:liver (rat) RGD PMID:17083329 RGD:2312274 NCBI chr17:11,002,818...11,109,974 JBrowse link
G KDR kinase insert domain receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
JBrowse link
G KRAS KRAS proto-oncogene, GTPase disease_progression ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (rat)
CTD
RGD
PMID:8603461 PMID:19533683 RGD:2315050 NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
JBrowse link
G LOC100739163 glutathione S-transferase P-like ISO protein:increased expression:liver (rat) RGD PMID:3965145 PMID:12016164 RGD:152998958 RGD:2317823 NCBI chr 2:4,978,761...4,982,233 JBrowse link
G LOC100739508 glutathione S-transferase P-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 NCBI chr 2:5,005,498...5,009,247 JBrowse link
G LOC110259471 macrophage-expressed gene 1 protein-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 2:12,472,927...12,475,116 JBrowse link
G MAP2K1 mitogen-activated protein kinase kinase 1 ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:liver RGD PMID:15520221 RGD:2306052 NCBI chr 1:164,381,892...164,469,313
Ensembl chr 1:164,381,845...164,471,226
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
JBrowse link
G MFGE8 milk fat globule EGF and factor V/VIII domain containing ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 7:54,539,970...54,554,885
Ensembl chr 7:54,539,970...54,571,747
JBrowse link
G MIR10A microRNA mir-10a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:24,833,644...24,833,723
Ensembl chr12:24,833,627...24,833,730
JBrowse link
G MIR125A microRNA mir-125a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645
JBrowse link
G MIR145 microRNA mir-145 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 2:150,580,126...150,580,211
Ensembl chr 2:150,580,126...150,580,211
JBrowse link
G MIR151 microRNA mir-151 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:2,849,041...2,849,120
Ensembl chr 4:2,849,038...2,849,130
JBrowse link
G MIR181C microRNA mir-181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 2:65,279,950...65,280,036
Ensembl chr 2:65,279,944...65,280,040
JBrowse link
G MIR183 microRNA mir-183 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr18:18,982,269...18,982,338
Ensembl chr18:18,982,269...18,982,338
JBrowse link
G MIR186 microRNA mir-186 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:141,943,328...141,943,409
Ensembl chr 6:141,943,328...141,943,409
JBrowse link
G MIR18A microRNA mir-18a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:60,734,791...60,734,882
Ensembl chr11:60,734,791...60,734,882
JBrowse link
G MIR195 microRNA mir-195 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:52,422,039...52,422,118
Ensembl chr12:52,422,039...52,422,118
JBrowse link
G MIR206 microRNA mir-206 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:45,976,293...45,976,372
Ensembl chr 7:45,976,293...45,976,372
JBrowse link
G MIR212 microRNA mir-212 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:48,163,054...48,163,135
Ensembl chr12:48,163,046...48,163,145
JBrowse link
G MIR221 microRNA mir-221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:40,571,068...40,571,137
Ensembl chr  X:40,571,068...40,571,137
JBrowse link
G MIR30A microRNA mir-30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:51,412,827...51,412,933
Ensembl chr 1:51,412,827...51,412,933
JBrowse link
G MIR30B microRNA mir-30b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:6,952,794...6,952,869
Ensembl chr 4:6,952,794...6,952,869
JBrowse link
G MIR30D microRNA mir-30d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 4:6,948,669...6,948,747
Ensembl chr 4:6,948,669...6,948,747
JBrowse link
G MIR30E microRNA mir-30e ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:170,429,841...170,429,920
Ensembl chr 6:170,429,841...170,429,920
JBrowse link
G MIR331 microRNA mir-331 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:88,028,339...88,028,418
Ensembl chr 5:88,028,339...88,028,418
JBrowse link
G MIR335 microRNA mir-335 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr18:18,341,580...18,341,659
Ensembl chr18:18,341,568...18,341,659
JBrowse link
G MIR339-2 microRNA mir-339-2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:164,025,972...164,026,057
Ensembl chr 1:164,025,972...164,026,057
JBrowse link
G MIR371 microRNA mir-371 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:56,427,208...56,427,285
Ensembl chr 6:56,427,208...56,427,285
JBrowse link
G MIR383 microRNA mir-383 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:2,698,041...2,698,122
Ensembl chr17:2,698,041...2,698,122
JBrowse link
G MIR505 microRNA mir-505 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:114,563,942...114,564,021
Ensembl chr  X:114,563,942...114,564,021
JBrowse link
G MIR652 microRNA mir-652 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:90,166,525...90,166,607
Ensembl chr  X:90,166,516...90,166,613
JBrowse link
G MIR671 microRNA mir-671 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr18:5,989,378...5,989,457
Ensembl chr18:5,989,355...5,989,466
JBrowse link
G MIR708 microRNA mir-708 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 9:13,780,171...13,780,250
Ensembl chr 9:13,780,171...13,780,250
JBrowse link
G MIR98 microRNA mir-98 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:46,302,381...46,302,460
Ensembl chr  X:46,302,381...46,302,460
JBrowse link
G MIR99B microRNA mir-99b ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:58,332,211...58,332,280
Ensembl chr 6:58,332,205...58,332,284
JBrowse link
G MIRLET7D microRNA let-7d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 3:43,468,501...43,468,596
Ensembl chr 3:43,468,501...43,468,596
JBrowse link
G MIRLET7E microRNA let-7e ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:58,332,042...58,332,121
Ensembl chr 6:58,332,036...58,332,120
JBrowse link
G MIRLET7I microRNA let-7i ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:27,252,802...27,252,886
Ensembl chr 5:27,252,787...27,252,894
JBrowse link
G MMP2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression, increased activity:liver
RGD
CTD
PMID:19528495 PMID:19539802 PMID:30603057 RGD:2325734 RGD:2325736 NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
JBrowse link
G MMP9 matrix metallopeptidase 9 ISO mRNA, protein:increased expression, increased activity:liver RGD PMID:19528495 PMID:19539802 RGD:2325734 RGD:2325736 NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (rat)
CTD
RGD
PMID:3335218 PMID:9079223 PMID:11280770 PMID:18560566 RGD:10059623 NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
JBrowse link
G NOS2 nitric oxide synthase 2 ISO protein:increased expression:liver RGD PMID:10383909 RGD:2325277 NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
JBrowse link
G NOTCH1 notch receptor 1 ISO protein:increased expression:liver RGD PMID:18942116 RGD:2325310
G NQO1 NAD(P)H quinone dehydrogenase 1 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:27867096 RGD:13442478 NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 susceptibility ISO RGD PMID:17283114 RGD:14701032 NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17172636 PMID:24769335 PMID:25656644 NCBI chr 4:89,226,314...89,231,781
Ensembl chr 4:89,226,690...89,236,431
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO human gene in mouse model RGD PMID:16286660 RGD:14975105 NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
JBrowse link
G PEMT phosphatidylethanolamine N-methyltransferase ISO protein:decreased expression:liver RGD PMID:7929120 RGD:1642378 NCBI chr12:60,880,367...60,919,279 JBrowse link
G PLCL1 phospholipase C like 1 disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr15:101,602,336...102,424,225
Ensembl chr15:101,840,806...101,951,106
JBrowse link
G PML PML nuclear body scaffold ISO CTD Direct Evidence: therapeutic CTD PMID:20377131 NCBI chr 7:59,405,044...59,450,155
Ensembl chr 7:59,405,053...59,450,105
JBrowse link
G PPAT phosphoribosyl pyrophosphate amidotransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:761203 NCBI chr 8:55,652,194...55,701,077
Ensembl chr 8:55,654,377...55,701,077
JBrowse link
G PPP2CA protein phosphatase 2 catalytic subunit alpha ISO mRNA:increased expression:liver (rat) RGD PMID:2562181 RGD:8693574 NCBI chr 2:136,497,780...136,522,630
Ensembl chr 2:136,494,541...136,522,646
JBrowse link
G PRDX1 peroxiredoxin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27517622 NCBI chr 6:165,847,390...165,859,918
Ensembl chr 6:165,824,395...165,861,442
JBrowse link
G PTGR1 prostaglandin reductase 1 ISO protein:increased expression:liver RGD PMID:24853774 RGD:14401713 NCBI chr 1:252,373,272...252,395,948
Ensembl chr 1:252,373,282...252,395,948
JBrowse link
G RAD51 RAD51 recombinase ISO protein:decreased expression:liver RGD PMID:17219426 RGD:2292638 NCBI chr 1:130,592,414...130,640,326
Ensembl chr 1:130,586,665...130,640,136
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17854601 NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
JBrowse link
G RGN regucalcin ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:41,725,660...41,749,736
Ensembl chr  X:41,726,526...41,749,381
JBrowse link
G RIDA reactive intermediate imine deaminase A homolog ISO protein:increased expression:liver (rat) RGD PMID:12939504 RGD:9685719 NCBI chr 4:38,656,270...38,665,863
Ensembl chr 4:38,656,319...38,670,987
JBrowse link
G RRAS2 RAS related 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr 2:44,890,129...44,961,003 JBrowse link
G RRM1 ribonucleotide reductase catalytic subunit M1 ISO RGD PMID:15224347 RGD:2316863 NCBI chr 9:6,026,151...6,065,211
Ensembl chr 9:6,025,073...6,065,143
JBrowse link
G RXRA retinoid X receptor alpha ISO mRNA, protein:decreased expression:liver RGD PMID:17786350 RGD:1643105 NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
JBrowse link
G SERPINA1 serpin family A member 1 ISO RGD PMID:10569800 RGD:1626391 NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
JBrowse link
G SLC31A1 solute carrier family 31 member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr 1:253,868,389...253,893,135
Ensembl chr 1:253,868,332...253,894,449
JBrowse link
G SLC7A5 solute carrier family 7 member 5 ISO mRNA:increased expression:liver RGD PMID:17498859 RGD:151357003 NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
JBrowse link
G SOCS1 suppressor of cytokine signaling 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15197228 NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
JBrowse link
G SOX4 SRY-box transcription factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr 7:16,886,834...16,895,488
Ensembl chr 7:16,891,319...16,892,752
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
JBrowse link
G SQLE squalene epoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 4:14,669,789...14,700,152
Ensembl chr 4:14,669,791...14,700,126
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26297436 PMID:28100771 NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
JBrowse link
G TEK TEK receptor tyrosine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 1:195,938,177...196,052,294
Ensembl chr 1:195,937,432...196,051,980
JBrowse link
G TGFA transforming growth factor alpha ISO protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9079223 PMID:16734725 RGD:2317490 NCBI chr 3:71,948,232...72,054,257
Ensembl chr 3:71,948,137...72,050,474
JBrowse link
G TGFB1 transforming growth factor beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
JBrowse link
G TK1 thymidine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917
JBrowse link
G TNF tumor necrosis factor treatment
disease_progression
ISO Morris hepatoma
protein:increased expression:blood serum (mouse)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9063767 PMID:26569409 PMID:28100771 RGD:11344640 RGD:14696818 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10626228 PMID:28100771 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
JBrowse link
G TSC22D1 TSC22 domain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15833021 PMID:17533171 NCBI chr11:22,518,792...22,634,411
Ensembl chr11:22,518,795...22,634,407
JBrowse link
G VIM vimentin ISO RGD PMID:19199359 RGD:6480440 NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
JBrowse link
G XDH xanthine dehydrogenase ISO protein:decreased expression:liver RGD PMID:3460692 RGD:13210515 NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
JBrowse link
Experimental Melanoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACSS1 acyl-CoA synthetase short chain family member 1 treatment ISO RGD PMID:27539851 RGD:13831304 NCBI chr17:30,800,536...30,839,799
Ensembl chr17:30,800,427...30,839,742
JBrowse link
G ACSS2 acyl-CoA synthetase short chain family member 2 treatment ISO RGD PMID:27539851 RGD:13831304 NCBI chr17:38,260,152...38,315,764
Ensembl chr17:38,260,147...38,315,757
JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 treatment ISO RGD PMID:19609240 PMID:19622764 RGD:9684925 RGD:9684939 NCBI chr 3:73,157,744...73,398,379
Ensembl chr 3:73,157,747...73,398,379
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 PMID:29438700 NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
JBrowse link
G CALR calreticulin ISO CTD Direct Evidence: therapeutic CTD PMID:16388313 NCBI chr 2:66,098,263...66,102,074
Ensembl chr 2:66,098,229...66,102,132
JBrowse link
G CCL20 C-C motif chemokine ligand 20 treatment ISO RGD PMID:14500387 RGD:7483600 NCBI chr15:129,172,743...129,176,069 JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 treatment ISO RGD PMID:24041689 RGD:7411680 NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
JBrowse link
G EGR1 early growth response 1 ISO mRNA, protein:increased expression:salivary gland (mouse) RGD PMID:19517020 RGD:5131885 NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
JBrowse link
G ESR2 estrogen receptor 2 severity ISO RGD PMID:20354658 RGD:8694122 NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
JBrowse link
G HGF hepatocyte growth factor ISO RGD PMID:9823327 RGD:8548620 NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
JBrowse link
G IFNB1 interferon beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:16417267 NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
JBrowse link
G IKBKB inhibitor of nuclear factor kappa B kinase subunit beta ISO RGD PMID:19276165 RGD:7495758 NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
JBrowse link
G IL18 interleukin 18 treatment ISO RGD PMID:12230493 PMID:17411412 RGD:8655870 RGD:8655901 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
JBrowse link
G IL1A interleukin 1 alpha treatment ISO RGD PMID:8061895 RGD:7794735 NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
JBrowse link
G IL2 interleukin 2 ISO RGD PMID:11884028 RGD:8662950 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
JBrowse link
G KDM1A lysine demethylase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 6:80,903,407...80,971,875
Ensembl chr 6:80,903,424...80,971,873
JBrowse link
G KDM4C lysine demethylase 4C ISO CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 1:215,071,335...215,507,778
Ensembl chr 1:215,071,419...215,507,800
JBrowse link
G LOC110258578 interleukin-1 beta-like ISO RGD PMID:1966551 RGD:7401226
G MC1R melanocortin 1 receptor ISO RGD PMID:20126537 RGD:5687319 NCBI chr 6:181,225...182,187
Ensembl chr 6:181,225...182,187
JBrowse link
G PDCD1 programmed cell death 1 treatment ISO RGD PMID:19208793 RGD:9589070 NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
JBrowse link
G PTEN phosphatase and tensin homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:29179997 NCBI chr14:99,929,590...100,021,619 JBrowse link
G PXN paxillin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18492274 NCBI chr14:40,227,894...40,278,785
Ensembl chr14:40,227,895...40,278,734
JBrowse link
G TERT telomerase reverse transcriptase treatment ISO RGD PMID:19903903 RGD:11038656 NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
JBrowse link
Experimental Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGPS alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr15:83,146,063...83,285,905
Ensembl chr15:83,146,002...83,391,984
JBrowse link
G ALB albumin ISO mRNA,protein:decreased expression:liver,serum: RGD PMID:1900492 RGD:11035284 NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
JBrowse link
G EPO erythropoietin ISO CTD Direct Evidence: therapeutic CTD PMID:9743294 NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
JBrowse link
G IFNG interferon gamma treatment ISO RGD PMID:2119881 RGD:10755752 NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO A to T transversion; Gln to His substitution RGD PMID:11295286 RGD:1598680 NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO DNA:transversion:exon p.Q61L (human) RGD PMID:11295286 RGD:1598680 NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
JBrowse link
G SLC6A14 solute carrier family 6 member 14 ISO mRNA, protein:increased expression:brush border epithelial cell RGD PMID:17006743 RGD:1625275 NCBI chr  X:95,482,494...95,507,200
Ensembl chr  X:95,482,456...95,527,369
JBrowse link
Mammary Neoplasms, Experimental term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 ISO RGD PMID:19654309 RGD:2315553 NCBI chr 9:93,049,955...93,146,469 JBrowse link
G ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 ISO CTD Direct Evidence: therapeutic CTD PMID:22767648 NCBI chr 8:130,853,414...130,945,388
Ensembl chr 8:130,889,684...130,945,393
JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:45,866,858...45,936,327
Ensembl chr15:45,866,857...45,963,729
JBrowse link
G ACTB actin beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:4,084,275...4,090,383
Ensembl chr 3:4,082,216...4,090,356
JBrowse link
G ACTG1 actin gamma 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:1,320,355...1,323,219
Ensembl chr12:1,313,641...1,323,217
JBrowse link
G ACTN4 actinin alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:47,493,834...47,565,999
Ensembl chr 6:47,493,919...47,565,998
JBrowse link
G ADCY5 adenylate cyclase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr13:136,965,746...137,133,795
Ensembl chr13:136,972,801...137,135,347
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing disease_progression
treatment
ISO RGD PMID:19447866 PMID:22246620 RGD:8694414 RGD:8694468 NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
JBrowse link
G AFP alpha fetoprotein ISO CTD Direct Evidence: therapeutic CTD PMID:16322315 NCBI chr 8:69,677,690...69,698,864
Ensembl chr 8:69,677,690...69,698,864
JBrowse link
G AGT angiotensinogen treatment ISO RGD PMID:20837666 RGD:5129167 NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
JBrowse link
G AGTR1 angiotensin II receptor type 1 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:8389152 PMID:18421211 RGD:2292665 NCBI chr13:88,934,873...88,980,317
Ensembl chr13:88,934,868...88,983,105
JBrowse link
G AGTR2 angiotensin II receptor type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:8389152 NCBI chr  X:95,267,709...95,272,237
Ensembl chr  X:95,269,300...95,270,388
JBrowse link
G AKT1 AKT serine/threonine kinase 1 ISO RGD PMID:17210696 RGD:2315600
G AKT2 AKT serine/threonine kinase 2 ISO RGD PMID:17210696 RGD:2315600 NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919
JBrowse link
G ALCAM activated leukocyte cell adhesion molecule ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr13:153,794,991...153,998,241
Ensembl chr13:153,794,993...153,998,208
JBrowse link
G ALOX5AP arachidonate 5-lipoxygenase activating protein ISO mRNA:increased expression:mammary gland tumor (rat) RGD PMID:18959458 RGD:2313895 NCBI chr11:7,371,328...7,438,111
Ensembl chr11:7,411,644...7,438,108
JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 disease_progression ISO RGD PMID:22085271 RGD:9684855 NCBI chr 3:73,157,744...73,398,379
Ensembl chr 3:73,157,747...73,398,379
JBrowse link
G ANXA1 annexin A1 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:12376462 PMID:16316942 RGD:2306898 NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
JBrowse link
G ANXA4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:72,623,311...72,654,591
Ensembl chr 3:72,622,358...72,694,212
JBrowse link
G APAF1 apoptotic peptidase activating factor 1 ISO RGD PMID:14973070 RGD:2325748 NCBI chr 5:85,166,616...85,258,751
Ensembl chr 5:85,166,628...85,258,364
JBrowse link
G APOE apolipoprotein E ISO RGD PMID:22469977 RGD:7771597 NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
JBrowse link
G AQP1 aquaporin 1 (Colton blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr18:42,063,482...42,076,741
Ensembl chr18:42,063,485...42,076,746
JBrowse link
G AR androgen receptor ISO RGD PMID:12150826 RGD:6482679 NCBI chr  X:53,609,113...53,806,778
Ensembl chr  X:53,609,176...53,800,677
JBrowse link
G AREG amphiregulin ISO mRNA:increased expression:mammary gland
protein:increased expression:mammary gland
RGD PMID:10225449 PMID:18421211 RGD:2292663 RGD:2292665 NCBI chr 8:70,417,935...70,428,106
Ensembl chr 8:70,417,923...70,428,102
JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 disease_progression ISO mRNA:increased expression:mammary gland RGD PMID:10939588 PMID:19703301 RGD:126848766 RGD:2316183 NCBI chr 7:67,494,237...67,631,461
Ensembl chr 7:67,494,941...67,594,197
JBrowse link
G ATP5IF1 ATP synthase inhibitory factor subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 6:85,307,242...85,309,211
Ensembl chr 6:85,307,189...85,309,215
JBrowse link
G AURKA aurora kinase A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12124350 NCBI chr17:56,954,838...56,972,435 JBrowse link
G BAD BCL2 associated agonist of cell death severity
treatment
ISO RGD PMID:20732338 PMID:23404339 RGD:10053670 RGD:10053708 NCBI chr 2:7,831,192...7,842,864
Ensembl chr 2:7,830,920...7,842,863
JBrowse link
G BAK1 BCL2 antagonist/killer 1 ISO RGD PMID:19222350 RGD:2315700 NCBI chr 7:29,808,849...29,815,345 JBrowse link
G BARD1 BRCA1 associated RING domain 1 ISO RGD PMID:18443292 RGD:2293149 NCBI chr15:117,049,483...117,135,889
Ensembl chr15:117,047,845...117,175,851
JBrowse link
G BASP1 brain abundant membrane attached signal protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr16:6,384,322...6,440,507 JBrowse link
G BAX BCL2 associated X, apoptosis regulator severity
treatment
ISO RGD PMID:20732338 PMID:23404339 RGD:10053670 RGD:10053708 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
JBrowse link
G BCL2L1 BCL2 like 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
JBrowse link
G BRCA1 BRCA1 DNA repair associated susceptibility ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:12203372 PMID:17505536 PMID:18443292 PMID:22767648 RGD:1599502 RGD:2293149 RGD:2293155 NCBI chr12:19,788,087...19,854,515
Ensembl chr12:19,786,020...19,854,668
JBrowse link
G BST2 bone marrow stromal cell antigen 2 disease_progression ISO RGD PMID:23806386 RGD:14398495 NCBI chr 2:60,305,306...60,308,295
Ensembl chr 2:60,305,283...60,309,697
JBrowse link
G CA9 carbonic anhydrase 9 ISO RGD PMID:17280655 RGD:2293194 NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822
JBrowse link
G CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase disease_progression ISO protein:increased expression:mammary gland RGD PMID:6030068 RGD:2303540 NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
JBrowse link
G CAPZB capping actin protein of muscle Z-line subunit beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:77,780,682...77,912,653
Ensembl chr 6:77,780,682...77,912,617
JBrowse link
G CASK calcium/calmodulin dependent serine protein kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr  X:37,166,973...37,535,723
Ensembl chr  X:37,167,577...37,536,160
JBrowse link
G CASP1 caspase 1, apoptosis-related cysteine peptidase treatment ISO RGD PMID:10557324 RGD:2315886 NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
JBrowse link
G CASP3 caspase 3 treatment
severity
ISO RGD PMID:20732338 PMID:23404339 PMID:26699876 RGD:10053670 RGD:10053708 RGD:13782283 NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
JBrowse link
G CASP7 caspase 7 treatment ISO RGD PMID:23404339 PMID:23979166 PMID:26699876 RGD:10053670 RGD:13209143 RGD:13782283 NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
JBrowse link
G CASP8 caspase 8 severity ISO RGD PMID:20732338 RGD:10053708 NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
JBrowse link
G CASP9 caspase 9 severity
treatment
ISO RGD PMID:17297389 PMID:20012353 PMID:20732338 PMID:26699876 RGD:10053708 RGD:13782283 RGD:2315928 RGD:2315933 NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
JBrowse link
G CAV1 caveolin 1 treatment
onset
ISO protein:decreased expression:mammary gland RGD PMID:9685399 PMID:15334058 PMID:15355971 RGD:2289100 RGD:2289106 RGD:8661780 NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
JBrowse link
G CCNA2 cyclin A2 ISO protein:increased expression:mammary gland RGD PMID:10713672 RGD:2293347 NCBI chr 8:102,260,346...102,266,274
Ensembl chr 8:102,260,215...102,266,309
JBrowse link
G CCNB1 cyclin B1 ISO RGD PMID:11146550 RGD:2315939 NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
JBrowse link
G CCND1 cyclin D1 ISO protein:decreased expression:mammary gland
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12376462 PMID:12602925 PMID:12649181 PMID:14522882 PMID:16316942 More... RGD:2289336 RGD:2289337 RGD:2292404 RGD:2296037 RGD:2306898 NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
JBrowse link
G CCND3 cyclin D3 ISO mRNA, protein:increased expression:mammary gland RGD PMID:12853979 PMID:16311245 RGD:2316015 RGD:2316020 NCBI chr 7:37,087,336...37,182,462
Ensembl chr 7:37,082,097...37,181,366
JBrowse link
G CCNE1 cyclin E1 ISO protein:decreased expression:mammary gland RGD PMID:12602925 PMID:12649181 RGD:2289336 RGD:2289337 NCBI chr 6:39,919,541...39,933,224
Ensembl chr 6:39,919,624...39,933,366
JBrowse link
G CCNH cyclin H ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland
CTD
RGD
PMID:12606953 RGD:9590264 NCBI chr 2:94,980,938...95,019,053
Ensembl chr 2:94,980,941...95,018,634
JBrowse link
G CCR2 C-C motif chemokine receptor 2 ISO RGD PMID:21621198 RGD:6893427 NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,376,343
JBrowse link
G CCR5 C-C motif chemokine receptor 5 ISO RGD PMID:14597737 PMID:22637726 RGD:8551810 RGD:8551813 NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
JBrowse link
G CD274 CD274 molecule treatment ISO RGD PMID:29043842 RGD:40886270 NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724
JBrowse link
G CD40 CD40 molecule ISO RGD PMID:21137078 RGD:8547744 NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
JBrowse link
G CD44 CD44 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
JBrowse link
G CDC25A cell division cycle 25A ISO RGD PMID:16951165 PMID:17283130 PMID:17638870 RGD:2754551 RGD:2764000 RGD:2771824
G CDC42 cell division cycle 42 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:80,035,034...80,089,243
Ensembl chr 6:80,035,123...80,089,233
JBrowse link
G CDH1 cadherin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
JBrowse link
G CDH13 cadherin 13 severity ISO RGD PMID:18316604 RGD:2293540 NCBI chr 6:4,809,752...5,832,188
Ensembl chr 6:4,808,255...5,832,415
JBrowse link
G CDK2 cyclin dependent kinase 2 ISO RGD PMID:16924466 RGD:2293558 NCBI chr 5:21,365,723...21,372,170
Ensembl chr 5:21,365,764...21,372,168
JBrowse link
G CDK4 cyclin dependent kinase 4 susceptibility ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:mammary gland
CTD
RGD
PMID:12376462 PMID:14522882 PMID:16413469 PMID:25221644 RGD:2293577 RGD:2293581 NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
JBrowse link
G CDK6 cyclin dependent kinase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25221644 NCBI chr 9:72,510,858...72,765,631
Ensembl chr 9:72,518,101...72,764,129
JBrowse link
G CDKL2 cyclin dependent kinase like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25333262 NCBI chr 8:71,231,148...71,260,902
Ensembl chr 8:71,231,152...71,260,815
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B treatment ISO protein:increased expression:mammary gland RGD PMID:15844214 PMID:22651929 RGD:10045559 RGD:2293626 NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A disease_progression ISO RGD PMID:18060046 PMID:20681787 RGD:2289674 RGD:8552689 NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:133,959,250...134,041,258
Ensembl chr 8:133,959,247...134,041,258
JBrowse link
G CLU clusterin disease_progression ISO RGD PMID:23099883 RGD:8699504 NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764
JBrowse link
G CNN3 calponin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:122,504,450...122,528,351
Ensembl chr 4:122,504,433...122,528,348
JBrowse link
G COL18A1 collagen type XVIII alpha 1 chain severity ISO RGD PMID:10766159 RGD:70690 NCBI chr13:207,907,835...207,984,082
Ensembl chr13:207,940,948...207,982,938
JBrowse link
G COL5A1 collagen type V alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:273,934,219...274,083,264
Ensembl chr 1:273,971,971...274,085,111
JBrowse link
G CSF1 colony stimulating factor 1 ISO RGD PMID:15205327 RGD:2293710 NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900
JBrowse link
G CSN2 casein beta ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:9879772 PMID:16316942 RGD:2306898 NCBI chr 8:66,914,231...66,922,636
Ensembl chr 8:66,915,923...66,922,636
JBrowse link
G CSN3 casein kappa ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr 8:67,099,131...67,109,112
Ensembl chr 8:67,099,131...67,106,987
JBrowse link
G CSNK2A1 casein kinase 2 alpha 1 ISO RGD PMID:11827167 RGD:727632 NCBI chr17:34,692,960...34,748,067 JBrowse link
G CTNNB1 catenin beta 1 ISO protein:increased expression:mammary gland
DNA:missense mutations: :p.S33Y, p.S45F
RGD PMID:17510243 PMID:18060046 RGD:2289674 RGD:2289816 NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
JBrowse link
G DBI diazepam binding inhibitor, acyl-CoA binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:24,895,575...24,900,710
Ensembl chr15:24,895,522...24,906,372
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:21283680 PMID:29298894 RGD:151347446 NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584
JBrowse link
G DES desmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:121,428,539...121,435,426
Ensembl chr15:121,427,642...121,435,423
JBrowse link
G DIO1 iodothyronine deiodinase 1 ISO RGD PMID:11765219 RGD:727335 NCBI chr 6:158,376,744...158,392,745
Ensembl chr 6:158,375,602...158,392,754
JBrowse link
G DNMT3B DNA methyltransferase 3 beta treatment ISO RGD PMID:24447120 RGD:9588304 NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
JBrowse link
G DUSP1 dual specificity phosphatase 1 treatment ISO RGD PMID:20837666 RGD:5129167 NCBI chr16:51,457,924...51,461,095
Ensembl chr16:51,458,020...51,461,086
JBrowse link
G DUSP6 dual specificity phosphatase 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:93,303,058...93,307,510
Ensembl chr 5:93,302,975...93,307,504
JBrowse link
G EEF1A1 eukaryotic translation elongation factor 1 alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:92,421,235...92,425,053
Ensembl chr 1:92,421,230...92,425,044
JBrowse link
G EFEMP1 EGF containing fibulin extracellular matrix protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:85,407,677...85,473,251
Ensembl chr 3:85,407,677...85,473,252
JBrowse link
G EGFR epidermal growth factor receptor ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:2523869 PMID:8603490 PMID:17203220 RGD:2289979 NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
JBrowse link
G EIF5A eukaryotic translation initiation factor 5A ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:52,659,040...52,664,686 JBrowse link
G ENO1 enolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
JBrowse link
G EPCAM epithelial cell adhesion molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:93,169,800...93,185,221
Ensembl chr 3:93,168,852...93,185,653
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
JBrowse link
G EPO erythropoietin treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
JBrowse link
G EPOR erythropoietin receptor treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr 2:70,063,601...70,068,821
Ensembl chr 2:70,063,519...70,068,821
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 ISO CTD Direct Evidence: marker/mechanism
Androgen-dependent
CTD
RGD
PMID:1913683 PMID:8603490 PMID:12150826 PMID:17203220 PMID:25221644 RGD:2289920 RGD:2289979 RGD:6482679 NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 ISO RGD PMID:17203220 RGD:2289979 NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038
JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 ISO RGD PMID:17203220 RGD:2289979 NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565
JBrowse link
G ESR1 estrogen receptor 1 susceptibility ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:epithelial cell, nucleus
RGD
CTD
PMID:11759285 PMID:15637090 PMID:18055862 RGD:2290019 RGD:8552983 RGD:8553057 NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
JBrowse link
G ESR2 estrogen receptor 2 treatment ISO protein:increased expression:epithelial cell, nucleus
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:15637090 PMID:24078029 RGD:7364911 RGD:8552983 NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
JBrowse link
G EZR ezrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:8,403,362...8,452,750
Ensembl chr 1:8,403,453...8,452,742
JBrowse link
G F11R F11 receptor ISO RGD PMID:22120722 RGD:7488922 NCBI chr 4:89,425,101...89,447,889
Ensembl chr 4:89,425,018...89,449,599
JBrowse link
G FABP4 fatty acid binding protein 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:55,096,400...55,101,209
Ensembl chr 4:55,096,404...55,101,896
JBrowse link
G FAS Fas cell surface death receptor ISO RGD PMID:18094967 RGD:2290047 NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
JBrowse link
G FBXO10 F-box protein 10 ISO RGD PMID:17404222 RGD:1601189 NCBI chr 1:238,232,855...238,308,661
Ensembl chr 1:238,232,867...238,308,625
JBrowse link
G FGF10 fibroblast growth factor 10 ISO mRNA:increased expression:mammary gland RGD PMID:18421211 RGD:2292665 NCBI chr16:28,695,465...28,779,953
Ensembl chr16:28,695,470...28,777,509
JBrowse link
G FGF7 fibroblast growth factor 7 ISO RGD PMID:9000125 RGD:2301094 NCBI chr 1:122,215,878...122,278,705
Ensembl chr 1:122,215,882...122,277,750
JBrowse link
G FGF8 fibroblast growth factor 8 ISO RGD PMID:9840935 RGD:2301098 NCBI chr14:112,808,215...112,814,225
Ensembl chr14:112,808,162...112,814,248
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 ISO RGD PMID:10498246 RGD:2302211 NCBI chr11:5,370,475...5,455,439
Ensembl chr11:5,370,496...5,455,358
JBrowse link
G FN1 fibronectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014
JBrowse link
G FRMPD1 FERM and PDZ domain containing 1 ISO RGD PMID:17404222 RGD:1601189 NCBI chr 1:238,371,311...238,511,714
Ensembl chr 1:238,371,336...238,511,715
JBrowse link
G FURIN furin, paired basic amino acid cleaving enzyme ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 7:53,455,634...53,472,791
Ensembl chr 7:53,460,017...53,472,787
JBrowse link
G G0S2 G0/G1 switch 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:133,287,065...133,288,066
Ensembl chr 9:133,287,325...133,287,742
JBrowse link
G GATA3 GATA binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:63,367,684...63,397,977
Ensembl chr10:63,367,663...63,388,859
JBrowse link
G GATM glycine amidinotransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:126,361,968...126,378,705
Ensembl chr 1:126,361,945...126,380,871
JBrowse link
G GDA guanine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:225,425,389...225,589,835
Ensembl chr 1:225,403,138...225,589,827
JBrowse link
G GNAI2 G protein subunit alpha i2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr13:32,705,326...32,733,804
Ensembl chr13:32,705,321...32,733,794
JBrowse link
G GSK3B glycogen synthase kinase 3 beta treatment ISO RGD PMID:28810530 RGD:13792729 NCBI chr13:140,136,109...140,370,197
Ensembl chr13:140,136,158...140,369,569
JBrowse link
G GSN gelsolin ISO mRNA:decreased expression RGD PMID:8895730 RGD:1599869 NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
JBrowse link
G GSS glutathione synthetase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr17:38,316,199...38,342,253
Ensembl chr17:38,312,720...38,342,298
JBrowse link
G H2AX H2A.X variant histone treatment ISO RGD PMID:22384017 RGD:7240549 NCBI chr 9:46,308,824...46,310,494
Ensembl chr 9:46,309,653...46,310,084
JBrowse link
G H3-3B H3.3 histone B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:5,632,326...5,634,977
Ensembl chr12:5,632,365...5,634,726
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha treatment ISO RGD PMID:17280655 RGD:2293194 NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO CTD Direct Evidence: therapeutic CTD
RGD
PMID:16319139 PMID:23215791 RGD:10755708
G HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
JBrowse link
G HNRNPAB heterogeneous nuclear ribonucleoprotein A/B ISO CTD Direct Evidence: marker/mechanism CTD PMID:15538050 NCBI chr 2:80,186,998...80,194,155 JBrowse link
G HP haptoglobin treatment ISO RGD PMID:23880232 RGD:11041861 NCBI chr 6:14,980,382...14,985,245 JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO CTD Direct Evidence: marker/mechanism
DNA:mutation: :p.G12E (rat)
CTD
RGD
PMID:8185828 PMID:11376698 PMID:19652463 RGD:2314834 NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
JBrowse link
G ID1 inhibitor of DNA binding 1, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr17:35,316,518...35,317,742
Ensembl chr17:35,316,514...35,317,736
JBrowse link
G ID3 inhibitor of DNA binding 3, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:81,422,541...81,424,169
Ensembl chr 6:81,422,546...81,424,075
JBrowse link
G ID4 inhibitor of DNA binding 4, HLH protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:14633621 NCBI chr 7:15,281,535...15,284,895
Ensembl chr 7:15,281,757...15,282,839
JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276 RGD:8549490 NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
JBrowse link
G IL10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14999141 NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
JBrowse link
G IL18BP interleukin 18 binding protein ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr 9:6,586,602...6,596,423
Ensembl chr 9:6,488,808...6,591,333
JBrowse link
G IL1RN interleukin 1 receptor antagonist treatment ISO human protein in a mouse model RGD PMID:21890879 RGD:6771361
G IL6ST interleukin 6 cytokine family signal transducer ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr16:35,101,304...35,151,832
Ensembl chr16:35,101,306...35,192,220
JBrowse link
G ILK integrin linked kinase ISO late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands RGD PMID:11704830 RGD:2301733 NCBI chr 9:3,145,647...3,152,097
Ensembl chr 9:3,145,608...3,159,858
JBrowse link
G INSIG1 insulin induced gene 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr18:2,885,494...2,898,758
Ensembl chr18:2,885,612...2,898,767
JBrowse link
G ITGB3 integrin subunit beta 3 ISO protein:increased expression:mammary gland: RGD PMID:22022542 RGD:8693386 NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
JBrowse link
G KDR kinase insert domain receptor ISO inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ RGD PMID:15170218 PMID:19888452 RGD:2291936 RGD:5684399 NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase ISO DNA:mutation (rat) RGD PMID:18445266 RGD:2302172 NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:94,016,992...94,110,219
Ensembl chr 5:94,017,387...94,110,214
JBrowse link
G KRT5 keratin 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:17,862,047...17,868,397
Ensembl chr 5:17,862,051...17,868,402
JBrowse link
G KRT7 keratin 7 ISO RGD PMID:8570173 RGD:2317439 NCBI chr 5:17,553,192...17,570,582
Ensembl chr 5:17,555,728...17,570,581
JBrowse link
G KRT71 keratin 71 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:17,895,714...17,905,194
Ensembl chr 5:17,895,718...17,905,181
JBrowse link
G LEP leptin treatment ISO RGD PMID:22246620 RGD:8694468 NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
JBrowse link
G LGALS7 galectin 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:47,588,983...47,604,520 JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor ISO mRNA:splice variant (rat) RGD PMID:15044717 RGD:2302177 NCBI chr 3:91,964,415...92,023,821
Ensembl chr 3:91,964,415...92,021,398
JBrowse link
G LIN7A lin-7 homolog A, crumbs cell polarity complex component ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:100,533,630...100,686,709
Ensembl chr 5:100,538,065...100,674,551
JBrowse link
G LNPEP leucyl and cystinyl aminopeptidase ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:serum
CTD
RGD
PMID:16619500 RGD:1582109 NCBI chr 2:103,568,366...103,659,589
Ensembl chr 2:103,567,602...103,661,070
JBrowse link
G LOC100624785 tubulin beta-2A chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 7:1,910,585...1,914,668
Ensembl chr 7:1,910,269...1,914,761
JBrowse link
G LOC100737977 tumor necrosis factor receptor superfamily member 10B-like ISO RGD PMID:17671220 RGD:2290495 NCBI chr14:7,344,788...7,371,086 JBrowse link
G LOC110259958 hemoglobin subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:41,482,353...41,483,564 JBrowse link
G LPL lipoprotein lipase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:4,104,761...4,134,964
Ensembl chr14:4,104,772...4,135,814
JBrowse link
G LSR lipolysis stimulated lipoprotein receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 6:44,759,091...44,773,378
Ensembl chr 6:44,759,073...44,773,379
JBrowse link
G MAP2K3 mitogen-activated protein kinase kinase 3 ISO RGD PMID:24233520 RGD:7495808 NCBI chr12:61,396,337...61,417,333
Ensembl chr12:61,396,369...61,417,321
JBrowse link
G MAP2K7 mitogen-activated protein kinase kinase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21317887 NCBI chr 2:71,299,010...71,308,432
Ensembl chr 2:71,298,325...71,308,124
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
JBrowse link
G MDH2 malate dehydrogenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:10,120,121...10,132,705
Ensembl chr 3:10,120,083...10,132,752
JBrowse link
G MGP matrix Gla protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 5:57,665,272...57,669,360
Ensembl chr 5:57,665,248...57,669,764
JBrowse link
G MIF macrophage migration inhibitory factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
JBrowse link
G MIR155 microRNA mir-155 ISO RGD PMID:20354188 PMID:29643534 RGD:21079418 RGD:21403681 NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
JBrowse link
G MMP1 matrix metallopeptidase 1 treatment ISO RGD PMID:19622769 RGD:8549722 NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
JBrowse link
G MMP13 matrix metallopeptidase 13 severity ISO RGD PMID:18698413 RGD:2306081 NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162
JBrowse link
G MMP15 matrix metallopeptidase 15 ISO mRNA:increased expression:mammary gland RGD PMID:15895410 RGD:2314949 NCBI chr 6:19,890,867...19,912,941
Ensembl chr 6:19,891,107...19,912,913
JBrowse link
G MMP2 matrix metallopeptidase 2 treatment ISO protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:19725228 PMID:23359979 PMID:28574600 RGD:2325823 RGD:8657038 NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
JBrowse link
G MMP3 matrix metallopeptidase 3 ISO RGD PMID:10428026 RGD:8662909 NCBI chr 9:33,446,969...33,453,995
Ensembl chr 9:33,446,836...33,454,000
JBrowse link
G MMP7 matrix metallopeptidase 7 onset ISO RGD PMID:9850086 RGD:9685350 NCBI chr 9:33,214,590...33,225,080
Ensembl chr 9:33,214,594...33,225,080
JBrowse link
G MMP9 matrix metallopeptidase 9 treatment ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland
CTD
RGD
PMID:19725228 PMID:21283680 PMID:23359979 RGD:2325823 RGD:8657038 NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
JBrowse link
G MPZL1 myelin protein zero like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:83,235,712...83,309,620
Ensembl chr 4:83,235,714...83,316,405
JBrowse link
G MRC2 mannose receptor C type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:16,059,759...16,119,571
Ensembl chr12:16,059,768...16,119,571
JBrowse link
G MT-CO1 mitochondrially encoded cytochrome c oxidase I ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr MT:6,511...8,055
Ensembl chr MT:6,511...8,055
JBrowse link
G MTOR mechanistic target of rapamycin kinase ISO RGD PMID:22349822 RGD:10040957 NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
JBrowse link
G MUC1 mucin 1, cell surface associated treatment ISO RGD PMID:23015160 RGD:7349374 NCBI chr 4:94,626,317...94,631,194 JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor treatment ISO RGD PMID:22384017 RGD:7240549 NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
JBrowse link
G NCOA1 nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21080969 NCBI chr 3:113,997,214...114,251,080
Ensembl chr 3:113,999,253...114,250,298
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO RGD PMID:22072621 RGD:10412719 NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
JBrowse link
G NOTCH4 notch receptor 4 ISO RGD PMID:15531924 RGD:2299154 NCBI chr 7:24,231,293...24,256,281
Ensembl chr 7:24,231,293...24,256,281
JBrowse link
G NSMF NMDA receptor synaptonuclear signaling and neuronal migration factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462
G NUDT1 nudix hydrolase 1 ISO mRNA:increased expression:mammary gland RGD PMID:12036445 RGD:724605 NCBI chr 3:1,567,417...1,575,801
Ensembl chr 3:1,566,915...1,576,234
JBrowse link
G OXT oxytocin/neurophysin I prepropeptide ISO CTD Direct Evidence: therapeutic CTD PMID:8647655 PMID:15089975 NCBI chr17:32,605,586...32,606,449
Ensembl chr17:32,605,586...32,606,546
JBrowse link
G PADI4 peptidyl arginine deiminase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:75,935,909...75,966,275
Ensembl chr 6:75,935,889...75,966,293
JBrowse link
G PAK4 p21 (RAC1) activated kinase 4 ISO RGD PMID:20697354 RGD:7775027 NCBI chr 6:47,869,604...47,914,185
Ensembl chr 6:47,869,577...47,914,182
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
JBrowse link
G PCNA proliferating cell nuclear antigen ISO mRNA,protein:increased expression:mammary gland: RGD PMID:2567593 RGD:10448972 NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
JBrowse link
G PCP4 Purkinje cell protein 4 ISO mRNA,protein:increased expression:cytoplasm: RGD PMID:19480007 RGD:9850273 NCBI chr13:203,412,479...203,479,216
Ensembl chr13:203,412,479...203,479,209
JBrowse link
G PDGFA platelet derived growth factor subunit A ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:16316942 RGD:2292404 RGD:2306898 NCBI chr 3:296,399...322,967
Ensembl chr 3:301,584...321,712
JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:34,523,901...34,530,238 JBrowse link
G PGAM1 phosphoglycerate mutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:108,822,782...108,832,818
Ensembl chr14:108,822,812...108,833,058
JBrowse link
G PGR progesterone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15637090 NCBI chr 9:32,035,684...32,129,776
Ensembl chr 9:32,035,684...32,129,221
JBrowse link
G PHB1 prohibitin 1 ISO mRNA, protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12376462 RGD:2292404 NCBI chr12:25,596,520...25,609,693
Ensembl chr12:25,596,523...25,609,706
JBrowse link
G PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr16:46,434,757...46,523,626
Ensembl chr16:46,511,521...46,523,609
JBrowse link
G PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 ISO RGD PMID:22064478 RGD:8693420 NCBI chr 2:68,715,898...68,729,471
Ensembl chr 2:68,715,880...68,729,870
JBrowse link
G PKM pyruvate kinase, muscle ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:60,971,807...61,032,780
Ensembl chr 7:60,975,667...61,004,316
Ensembl chr 7:60,975,667...61,004,316
JBrowse link
G PLAU plasminogen activator, urokinase disease_progression ISO RGD PMID:18052026 RGD:6484140 NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
JBrowse link
G PLK2 polo like kinase 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 RGD:2292404 NCBI chr16:37,299,116...37,305,114
Ensembl chr16:37,299,119...37,305,114
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:11137312 NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
JBrowse link
G PRDX2 peroxiredoxin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:66,207,829...66,211,474
Ensembl chr 2:66,207,828...66,212,009
JBrowse link
G PRL prolactin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
JBrowse link
G PRLR prolactin receptor ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr16:20,637,568...20,655,881
Ensembl chr16:20,618,875...20,810,140
JBrowse link
G PSMA4 proteasome 20S subunit alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:47,440,576...47,448,599
Ensembl chr 7:47,434,919...47,448,891
JBrowse link
G PSME1 proteasome activator subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:75,161,830...75,164,531
Ensembl chr 7:75,160,766...75,164,810
JBrowse link
G PTBP1 polypyrimidine tract binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:77,551,562...77,563,153
Ensembl chr 2:77,551,562...77,563,134
JBrowse link
G PTEN phosphatase and tensin homolog onset ISO RGD PMID:18381417 RGD:2292496 NCBI chr14:99,929,590...100,021,619 JBrowse link
G PTGER1 prostaglandin E receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11751431 NCBI chr 2:64,796,944...64,800,199
Ensembl chr 2:64,797,216...64,800,458
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO mRNA:increased expression:breast RGD PMID:18279516 PMID:18676768 PMID:21623034 RGD:2300118 RGD:2300130 RGD:5135030 NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
JBrowse link
G PTK2 protein tyrosine kinase 2 disease_progression ISO CTD Direct Evidence: therapeutic RGD
CTD
PMID:15930288 PMID:18056629 PMID:24809783 RGD:2292554 RGD:2292560 NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054
JBrowse link
G PTN pleiotrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr18:12,219,708...12,309,045
Ensembl chr18:12,219,787...12,309,044
JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO RGD PMID:23899555 RGD:151660352 NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289
JBrowse link
G RAN RAN, member RAS oncogene family ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr14:24,312,810...24,318,024
Ensembl chr14:24,311,577...24,317,789
JBrowse link
G RASA1 RAS p21 protein activator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 2:94,879,615...94,992,725
Ensembl chr 2:94,878,911...94,993,450
JBrowse link
G RASGRF2 Ras protein specific guanine nucleotide releasing factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 2:89,525,948...89,794,103
Ensembl chr 2:89,528,111...89,790,719
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14522882 NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
JBrowse link
G RBP1 retinol binding protein 1 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 RGD:2292404 NCBI chr13:80,380,958...80,407,328
Ensembl chr13:80,380,962...80,407,458
JBrowse link
G RBP4 retinol binding protein 4 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 RGD:2306898 NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765
JBrowse link
G RCN1 reticulocalbin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:28,696,528...28,714,083
Ensembl chr 2:28,696,661...28,709,672
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO protein:decreased expression:peritoneal macrophage RGD PMID:16288051 RGD:2298764 NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit ISO RGD PMID:16260626 RGD:7777148 NCBI chr 6:51,444,670...51,480,350
Ensembl chr 6:51,444,664...51,480,319
JBrowse link
G RNPEP arginyl aminopeptidase ISO protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:16619500 RGD:1582109 NCBI chr10:24,218,144...24,235,520
Ensembl chr10:24,218,139...24,235,518
JBrowse link
G RPL3 ribosomal protein L3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:8,922,697...8,929,768
Ensembl chr 5:8,922,665...8,929,767
JBrowse link
G RPL6 ribosomal protein L6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:39,302,447...39,309,239
Ensembl chr14:39,303,350...39,309,236
JBrowse link
G RPS14 ribosomal protein S14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:151,430,047...151,433,951
Ensembl chr 2:151,430,049...151,433,856
JBrowse link
G RUNX1 RUNX family transcription factor 1 ISO mRNA:increased expression:mammary gland RGD PMID:29435983 RGD:126779584 NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
JBrowse link
G RXRA retinoid X receptor alpha ISO RGD PMID:16344269 RGD:1643109 NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
JBrowse link
G S100A6 S100 calcium binding protein A6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:96,098,264...96,099,686
Ensembl chr 4:96,098,525...96,099,684
JBrowse link
G S1PR1 sphingosine-1-phosphate receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:117,064,632...117,069,724
Ensembl chr 4:117,064,755...117,069,650
JBrowse link
G SCARB1 scavenger receptor class B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr14:28,301,421...28,393,568
Ensembl chr14:28,301,294...28,393,568
JBrowse link
G SCD stearoyl-CoA desaturase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020
JBrowse link
G SELENOP selenoprotein P ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr16:27,537,885...27,547,863
Ensembl chr16:27,537,885...27,631,130
JBrowse link
G SGK1 serum/glucocorticoid regulated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:29,625,786...29,753,619
Ensembl chr 1:29,745,114...29,753,602
JBrowse link
G SLC12A2 solute carrier family 12 member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:131,016,430...131,109,307
Ensembl chr 2:131,016,418...131,109,299
JBrowse link
G SLC25A10 solute carrier family 25 member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:1,191,242...1,197,439
Ensembl chr12:1,189,903...1,197,301
JBrowse link
G SNCG synuclein gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:87,916,353...87,922,111
Ensembl chr14:87,904,659...87,922,095
JBrowse link
G SNRPD3 small nuclear ribonucleoprotein D3 polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:49,585,177...49,598,015 JBrowse link
G SOCS1 suppressor of cytokine signaling 1 ISO mRNA:increased expression:mammary gland RGD PMID:18381452 PMID:20354188 RGD:21079418 RGD:2298899 NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
JBrowse link
G SOCS3 suppressor of cytokine signaling 3 ISO mRNA:increased expression:mammary gland RGD PMID:18381452 RGD:2298899 NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
JBrowse link
G SOD2 superoxide dismutase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23964924 NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
JBrowse link
G SOX9 SRY-box transcription factor 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:8,642,154...8,647,315
Ensembl chr12:8,642,158...8,647,315
JBrowse link
G SPINT2 serine peptidase inhibitor, Kunitz type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:47,181,772...47,210,564
Ensembl chr 6:47,181,768...47,210,559
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:15318939 NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
JBrowse link
G SRSF2 serine and arginine rich splicing factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:4,800,578...4,803,767
Ensembl chr12:4,800,624...4,801,675
JBrowse link
G STAT1 signal transducer and activator of transcription 1 ISO RGD PMID:11325527 RGD:2291895 NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:17483332 RGD:2291914 RGD:2306898 NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
JBrowse link
G STAT5A signal transducer and activator of transcription 5A susceptibility ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
protein:increased tyrosine phosphorylation:mammary gland
protein:altered localization:nucleus
CTD
RGD
PMID:12082622 PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 More... RGD:151665819 RGD:2291927 RGD:2291932 RGD:2292404 RGD:2298539 RGD:2306898 NCBI chr12:20,474,221...20,498,785
Ensembl chr12:20,474,227...20,499,138
JBrowse link
G STAT6 signal transducer and activator of transcription 6 ISO DNA:gene knockout::Balb/C-derived Stat6(-/-) mice resistant to growth of implanted Balb/C mammary tumors RGD PMID:11086031 RGD:2298563 NCBI chr 5:22,406,356...22,422,412
Ensembl chr 5:22,406,368...22,421,989
JBrowse link
G STC2 stanniocalcin 2 ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr16:50,989,676...51,001,412
Ensembl chr16:50,989,433...51,004,481
JBrowse link
G STMN1 stathmin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:83,356,404...83,362,546
Ensembl chr 6:83,356,412...83,362,500
JBrowse link
G TDG thymine DNA glycosylase ISO mRNA:increased expression:mammary gland tumor (mouse) RGD PMID:9794235 RGD:2317355 NCBI chr 5:80,473,233...80,492,295
Ensembl chr 5:80,473,234...80,492,287
JBrowse link
G TF transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:9879772 PMID:16316942 NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
JBrowse link
G TFF1 trefoil factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr13:205,687,558...205,691,512
Ensembl chr13:205,687,560...205,691,460
JBrowse link
G TGFA transforming growth factor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:8603490 NCBI chr 3:71,948,232...72,054,257
Ensembl chr 3:71,948,137...72,050,474
JBrowse link
G TGFB1 transforming growth factor beta 1 ISO RGD PMID:8466857 RGD:7394797 NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 ISO RGD PMID:12808151 RGD:737735 NCBI chr 1:240,842,735...240,918,267
Ensembl chr 1:240,860,156...240,918,528
JBrowse link
G TGFBR2 transforming growth factor beta receptor 2 ISO RGD PMID:12808151 RGD:737735 NCBI chr13:16,784,370...16,875,828
Ensembl chr13:16,784,490...16,878,160
JBrowse link
G THBS1 thrombospondin 1 ISO mRNA:increased expression:mammary gland RGD PMID:15459484 RGD:1626167 NCBI chr 1:131,728,781...131,746,098
Ensembl chr 1:131,728,784...131,746,115
JBrowse link
G THRSP thyroid hormone responsive ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:12,479,913...12,484,323
Ensembl chr 9:12,479,907...12,488,557
JBrowse link
G TKT transketolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr13:35,348,921...35,377,518
Ensembl chr13:35,348,915...35,377,587
JBrowse link
G TLE4 TLE family member 4, transcriptional corepressor ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:232,355,959...232,504,766
Ensembl chr 1:232,355,959...232,504,763
JBrowse link
G TNF tumor necrosis factor ISO RGD PMID:19755514 RGD:7401185 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TNFSF10 TNF superfamily member 10 ISO CTD Direct Evidence: therapeutic CTD PMID:21252285 NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
JBrowse link
G TP53 tumor protein p53 disease_progression ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:17470299 PMID:18092324 PMID:24809783 RGD:2290539 RGD:2290577 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
JBrowse link
G TPM3 tropomyosin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 4:95,542,329...95,572,946
Ensembl chr 4:95,542,473...95,572,938
JBrowse link
G TRPS1 transcriptional repressor GATA binding 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:22,905,627...23,162,862
Ensembl chr 4:22,905,637...23,159,546
JBrowse link
G TSC22D1 TSC22 domain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:22,518,792...22,634,411
Ensembl chr11:22,518,795...22,634,407
JBrowse link
G TXNIP thioredoxin interacting protein severity ISO mRNA:decreased expression:mammary gland RGD PMID:15170812 RGD:1642758 NCBI chr 4:99,348,589...99,351,760
Ensembl chr 4:99,348,490...99,352,755
JBrowse link
G TYMS thymidylate synthetase ISO RGD PMID:9635926 RGD:2315839 NCBI chr 6:105,642,730...105,660,279
Ensembl chr 6:105,642,381...105,660,578
JBrowse link
G UBE2I ubiquitin conjugating enzyme E2 I ISO MCF-7 human breast cancer cell tumors grown in nude mice
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:15735760 PMID:16316942 RGD:2301345 NCBI chr 3:40,556,556...40,586,382 JBrowse link
G UCP2 uncoupling protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 9:8,358,559...8,364,552
Ensembl chr 9:8,358,025...8,365,547
JBrowse link
G VAMP8 vesicle associated membrane protein 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:59,187,900...59,193,165
Ensembl chr 3:59,185,735...59,193,128
JBrowse link
G VDR vitamin D receptor ISO RGD PMID:15333467 RGD:8158073 NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
JBrowse link
G VEGFA vascular endothelial growth factor A treatment ISO human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
JBrowse link
G WNT1 Wnt family member 1 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr 5:15,010,607...15,015,007
Ensembl chr 5:15,010,786...15,014,998
JBrowse link
G WNT2 Wnt family member 2 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr18:28,945,825...28,993,969
Ensembl chr18:28,946,326...28,993,961
JBrowse link
G WNT3 Wnt family member 3 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 RGD:2298848 NCBI chr12:17,627,291...17,681,197
Ensembl chr12:17,628,726...17,681,026
JBrowse link
G WNT3A Wnt family member 3A ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr 2:51,153,978...51,203,678
Ensembl chr 2:51,153,970...51,202,176
JBrowse link
G WNT5B Wnt family member 5B no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr 5:68,627,158...68,731,938
Ensembl chr 5:68,627,185...68,732,265
JBrowse link
G WNT6 Wnt family member 6 no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr15:120,901,471...120,917,359
Ensembl chr15:120,901,376...120,917,486
JBrowse link
G WNT7A Wnt family member 7A ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr13:70,538,802...70,602,464
Ensembl chr13:70,538,894...70,602,454
JBrowse link
G WNT7B Wnt family member 7B no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298848 RGD:2298863 NCBI chr 5:3,521,412...3,572,322
Ensembl chr 5:3,521,288...3,572,314
JBrowse link
G XDH xanthine dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
JBrowse link
G XIAP X-linked inhibitor of apoptosis ISO CTD Direct Evidence: therapeutic CTD PMID:12766084 NCBI chr  X:101,399,374...101,440,021
Ensembl chr  X:101,399,812...101,440,013
JBrowse link
G XRCC3 X-ray repair cross complementing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21283680
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 4:35,975,513...36,009,909
Ensembl chr 4:35,975,508...36,009,887
JBrowse link
Sarcoma, Yoshida term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DPYD dihydropyrimidine dehydrogenase treatment ISO RGD PMID:8138551 RGD:11251753 NCBI chr 4:119,931,471...120,712,461
Ensembl chr 4:119,931,414...120,712,459
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 14396
    disease of cellular proliferation 6772
      Experimental Neoplasms 463
        Carcinoma 256, Walker 0
        Carcinoma, Brown-Pearce 0
        Carcinoma, Krebs 2 0
        Carcinoma, Lewis Lung 11
        Ehrlich tumor carcinoma 3
        Experimental Leukemia + 9
        Experimental Liver Neoplasms 140
        Experimental Melanoma 23
        Experimental Sarcoma + 9
        Mammary Neoplasms, Experimental 281
Path 2
Term Annotations click to browse term
  disease 14396
    Animal Diseases 1273
      Animal Disease Models 1228
        Experimental Neoplasms 463
          Carcinoma 256, Walker 0
          Carcinoma, Brown-Pearce 0
          Carcinoma, Krebs 2 0
          Carcinoma, Lewis Lung 11
          Ehrlich tumor carcinoma 3
          Experimental Leukemia + 9
          Experimental Liver Neoplasms 140
          Experimental Melanoma 23
          Experimental Sarcoma + 9
          Mammary Neoplasms, Experimental 281
paths to the root